Advertisement
U.S. markets closed

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
3.9800-0.1500 (-3.63%)
At close: 04:00PM EST
3.9800 0.00 (0.00%)
After hours: 06:10PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close4.1300
Open4.1300
Bid4.0000 x 4000
Ask3.9400 x 3000
Day's Range3.9200 - 4.2200
52 Week Range3.5300 - 11.3600
Volume4,814,862
Avg. Volume7,638,446
Market Cap472.784M
Beta (5Y Monthly)1.46
PE Ratio (TTM)N/A
EPS (TTM)-6.2300
Earnings DateFeb 28, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est19.40
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NVAX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Novavax, Inc.
    Daily – Vickers Top Buyers & Sellers for 04/05/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    2 years agoArgus Research
View more
  • Zacks

    Novavax (NVAX) Q4 Earnings Preview: What's in the Cards?

    Novavax (NVAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • PR Newswire

    Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights on February 28, 2024

    Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will report its fourth quarter and full year 2023 financial results and operational highlights at 8:30 a.m. Eastern Standard Time (EST) on Wednesday, February 28, 2024. Details of the event and replay are as follows:

  • InvestorPlace

    Get Rich Quick With These 3 Stocks to Buy Now

    If you’re looking for stocks to buy now that will give you robust returns inside of one year, you’ve come to the right place. Here, my intention is to provide premium-level research for free, walking you to potential profits. However, as with anything in life, the higher the reward potential, the higher the risk. Essentially, we’re dealing with betting on which team will win the 2024 World Series before opening day. If you pick the Oakland Athletics, you’re probably going to lose your bet. But i